Figure 4
Begg’s funnel plots of BIM deletion polymorphism and response rate, disease control rate and progression-free survival in malignancy with kinase inhibitor therapy.
(A) BIM deletion polymorphism and response rate; (B) BIM deletion polymorphism and disease control rate; (C) BIM deletion polymorphism and progression-free survival.
